Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$19.22
0.935.08%
At close: -
$19.22
0.000.00%
After Hours: 4:40 PM EDT
Comments
Loading...
Staar Surgical Analyst Ratings and Price Targets | NASDAQ:STAA | Benzinga
Staar Surgical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Staar Surgical Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Wells Fargo
Stephens & Co.
Stifel
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Staar Surgical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/08/2025 | Buy Now | — | Canaccord Genuity | Jon Young40% | $17 → $20 | Maintains | Hold | Get Alert |
| 04/21/2025 | Buy Now | — | Wells Fargo | — | → $17 | Initiates | → Equal-Weight | Get Alert |
| 03/18/2025 | Buy Now | — | Stephens & Co. | Mason Carrico39% | $17 → $17 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 02/27/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 02/13/2025 | Buy Now | — | Canaccord Genuity | Jon Young40% | $28 → $17 | Maintains | Hold | Get Alert |
| 02/12/2025 | Buy Now | — | Stifel | Thomas Stephan40% | $38 → $20 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | — | Stephens & Co. | Mason Carrico39% | $28 → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 02/12/2025 | Buy Now | — | Piper Sandler | Matt O'Brien52% | $40 → $16 | Maintains | Neutral | Get Alert |
| 02/12/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 02/12/2025 | Buy Now | — | William Blair | Margaret Kaczor33% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/07/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 12/09/2024 | Buy Now | — | Canaccord Genuity | Jon Young40% | $31 → $28 | Maintains | Hold | Get Alert |
| 11/01/2024 | Buy Now | — | Canaccord Genuity | Jon Young40% | $41 → $31 | Maintains | Hold | Get Alert |
| 10/31/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 09/19/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 08/26/2024 | Buy Now | — | Stifel | Thomas Stephan40% | $50 → $44 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | — | Canaccord Genuity | Jon Young40% | $43 → $41 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 07/15/2024 | Buy Now | — | BTIG | Ryan Zimmerman71% | $46 → $53 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | — | Morgan Stanley | Patrick Wood51% | $50 → $37 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/15/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 06/11/2024 | Buy Now | — | BTIG | Ryan Zimmerman71% | → $46 | Upgrade | Neutral → Buy | Get Alert |
| 05/08/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 05/08/2024 | Buy Now | — | Canaccord Genuity | Jon Young40% | $46 → $43 | Maintains | Hold | Get Alert |
| 05/08/2024 | Buy Now | — | Piper Sandler | Matt O'Brien52% | $33 → $40 | Maintains | Neutral | Get Alert |
| 05/08/2024 | Buy Now | — | Mizuho | Anthony Petrone63% | $53 → $55 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | — | Mizuho | Anthony Petrone63% | $45 → $53 | Maintains | Buy | Get Alert |
| 04/08/2024 | Buy Now | — | Canaccord Genuity | Jon Young40% | $32 → $46 | Maintains | Hold | Get Alert |
| 04/04/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 04/01/2024 | Buy Now | — | Stifel | Thomas Stephan40% | $50 → $50 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | — | Stifel | Thomas Stephan40% | $30 → $50 | Upgrade | Hold → Buy | Get Alert |
| 02/28/2024 | Buy Now | — | Mizuho | Anthony Petrone63% | $50 → $45 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | — | Piper Sandler | Matt O'Brien52% | $40 → $33 | Maintains | Neutral | Get Alert |
| 12/05/2023 | Buy Now | — | Needham | David Saxon56% | — | Downgrade | Buy → Hold | Get Alert |
| 12/04/2023 | Buy Now | — | Morgan Stanley | Patrick Wood51% | → $35 | Initiates | → Equal-Weight | Get Alert |
| 11/02/2023 | Buy Now | — | Piper Sandler | Matt O'Brien52% | $45 → $40 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | — | Needham | David Saxon56% | $52 → $49 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | — | Stifel | Thomas Stephan40% | $45 → $40 | Maintains | Hold | Get Alert |
| 09/15/2023 | Buy Now | — | Piper Sandler | Matt O'Brien52% | $50 → $45 | Maintains | Neutral | Get Alert |
| 09/15/2023 | Buy Now | — | Mizuho | Anthony Petrone63% | → $65 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | Buy Now | — | Benchmark | Bruce Jackson39% | — | Downgrade | Buy → Hold | Get Alert |
| 09/15/2023 | Buy Now | — | Needham | David Saxon56% | $54 → $52 | Maintains | Buy | Get Alert |
| 09/13/2023 | Buy Now | — | Mizuho | Anthony Petrone63% | → $65 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2023 | Buy Now | — | Stifel | Thomas Stephan40% | → $45 | Reiterates | Hold → Hold | Get Alert |
| 08/21/2023 | Buy Now | — | Stifel | Thomas Stephan40% | $50 → $45 | Maintains | Hold | Get Alert |
| 08/14/2023 | Buy Now | — | Stephens & Co. | George Sellers39% | → $57 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | — | Stephens & Co. | George Sellers39% | $71 → $57 | Maintains | Overweight | Get Alert |
| 08/03/2023 | Buy Now | — | Piper Sandler | Matt O'Brien52% | $65 → $50 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | — | Needham | David Saxon56% | $75 → $58 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | — | Canaccord Genuity | William Plovanic59% | $77 → $48 | Downgrade | Buy → Hold | Get Alert |
| 06/12/2023 | Buy Now | — | Stifel | Thomas Stephan40% | $60 → $55 | Maintains | Hold | Get Alert |
| 06/08/2023 | Buy Now | — | Canaccord Genuity | William Plovanic59% | → $77 | Reiterates | → Buy | Get Alert |
| 06/07/2023 | Buy Now | — | William Blair | Margaret Kaczor33% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/24/2023 | Buy Now | — | Needham | David Saxon56% | → $75 | Reiterates | Buy → Buy | Get Alert |
| 05/04/2023 | Buy Now | — | Stephens & Co. | George Sellers39% | → $85 | Reiterates | → Overweight | Get Alert |
| 05/04/2023 | Buy Now | — | Needham | David Saxon56% | $78 → $84 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | — | Piper Sandler | Matt O'Brien52% | → $65 | Initiates | → Neutral | Get Alert |
| 02/22/2023 | Buy Now | — | Stephens & Co. | George Sellers39% | → $85 | Reiterates | → Overweight | Get Alert |
| 02/22/2023 | Buy Now | — | Needham | David Saxon56% | $83 → $78 | Maintains | Buy | Get Alert |
| 02/06/2023 | Buy Now | — | BTIG | Ryan Zimmerman71% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/01/2023 | Buy Now | — | Benchmark | Bruce Jackson39% | $78 → $75 | Maintains | Buy | Get Alert |
| 01/30/2023 | Buy Now | — | Canaccord Genuity | William Plovanic59% | $79 → $80 | Maintains | Buy | Get Alert |
| 01/20/2023 | Buy Now | — | Canaccord Genuity | William Plovanic59% | $76 → $79 | Maintains | Buy | Get Alert |
| 12/28/2022 | Buy Now | — | Stephens & Co. | George Sellers39% | $91 → $85 | Maintains | Overweight | Get Alert |
| 12/08/2022 | Buy Now | — | Stifel | Thomas Stephan40% | → $60 | Initiates | → Hold | Get Alert |
| 11/07/2022 | Buy Now | — | Sidoti & Co. | James Sidoti65% | — | Upgrade | Neutral → Buy | Get Alert |
| 11/03/2022 | Buy Now | — | BTIG | Ryan Zimmerman71% | $103 → $80 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | — | Needham | David Saxon56% | $110 → $83 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | — | Canaccord Genuity | William Plovanic59% | $97 → $88 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | — | Stephens & Co. | George Sellers39% | → $91 | Reinstates | → Overweight | Get Alert |
| 10/13/2022 | Buy Now | — | Mizuho | Anthony Petrone63% | → $85 | Initiates | → Buy | Get Alert |
| 08/11/2022 | Buy Now | — | Jefferies | Zachary Weiner2% | $165 → $125 | Maintains | Buy | Get Alert |
| 08/11/2022 | Buy Now | — | Benchmark | Bruce Jackson39% | $97 → $117 | Maintains | Buy | Get Alert |
| 08/11/2022 | Buy Now | — | Needham | David Saxon56% | $87 → $110 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Staar Surgical (STAA) stock?
The latest price target for Staar Surgical (NASDAQ:STAA) was reported by Canaccord Genuity on May 8, 2025. The analyst firm set a price target for $20.00 expecting STAA to rise to within 12 months (a possible 4.06% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Staar Surgical (STAA)?
The latest analyst rating for Staar Surgical (NASDAQ:STAA) was provided by Canaccord Genuity, and Staar Surgical maintained their hold rating.
When was the last upgrade for Staar Surgical (STAA)?
The last upgrade for Staar Surgical Co happened on June 11, 2024 when BTIG raised their price target to $46. BTIG previously had a neutral for Staar Surgical Co.
When was the last downgrade for Staar Surgical (STAA)?
The last downgrade for Staar Surgical Co happened on February 12, 2025 when William Blair changed their price target from N/A to N/A for Staar Surgical Co.
When is the next analyst rating going to be posted or updated for Staar Surgical (STAA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Staar Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Staar Surgical was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
Is the Analyst Rating Staar Surgical (STAA) correct?
While ratings are subjective and will change, the latest Staar Surgical (STAA) rating was a maintained with a price target of $17.00 to $20.00. The current price Staar Surgical (STAA) is trading at is $19.22, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
